Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Dow
Mallinckrodt
Cerilliant
Deloitte
Citi
McKinsey
Medtronic
UBS

Generated: September 24, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 040066

« Back to Dashboard

NDA 040066 describes SULFACETAMIDE SODIUM, which is a drug marketed by Fougera Pharms, Perrigo Co Tennessee, Taro, Akorn, Alcon Pharms Ltd, Bausch And Lomb, Pharmafair, and Sandoz Inc, and is included in twelve NDAs. It is available from seventeen suppliers. Additional details are available on the SULFACETAMIDE SODIUM profile page.

The generic ingredient in SULFACETAMIDE SODIUM is prednisolone sodium phosphate; sulfacetamide sodium. There are eighty-seven drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the prednisolone sodium phosphate; sulfacetamide sodium profile page.
Summary for 040066
Tradename:SULFACETAMIDE SODIUM
Applicant:Bausch And Lomb
Ingredient:sulfacetamide sodium
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 040066
Ingredient-typeSulfonamides
Medical Subject Heading (MeSH) Categories for 040066
Suppliers and Packaging for NDA: 040066
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
SULFACETAMIDE SODIUM sulfacetamide sodium SOLUTION/DROPS;OPHTHALMIC 040066 ANDA Bausch & Lomb Incorporated 24208-670 24208-670-04 1 BOTTLE, DROPPER in 1 CARTON (24208-670-04) > 15 mL in 1 BOTTLE, DROPPER
SULFACETAMIDE SODIUM sulfacetamide sodium SOLUTION/DROPS;OPHTHALMIC 040066 ANDA Lake Erie Medical DBA Quality Care Products LLC 49999-144 49999-144-15 15 mL in 1 BOTTLE, PLASTIC (49999-144-15)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION/DROPS;OPHTHALMICStrength10%
Approval Date:Dec 28, 1994TE:ATRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
US Department of Justice
Mallinckrodt
QuintilesIMS
Healthtrust
Daiichi Sankyo
McKinsey
Cipla
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.